Singapore: An US FDA panel has voted that Merck & Co experimental insomnia drug appears to be safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. The FDA is not obligated... Read more
Singapore: Johnson & Johnson (J&J) revealed that it is aiming to apply for approval of 10 new drugs in the US and Europe,... Read more
Singapore: Ranbaxy Laboratories is contemplating on slashing its global sales staff by about a third, with a majority of... Read more
Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement of the US Food and... Read more
Singapore: Ranbaxy Laboratories highlighted some of the major specific actions the company has been taking in recent years to address certain... Read more
Singapore: Sanofi joined hands with Axway in order to streamline processes and transform its technology infrastructure into an efficient... Read more
Singapore: GlaxoSmithKline (GSK) launched Discovery Fast Track, a competition designed to accelerate the translation of academic research... Read more
Singapore: Pfizer has discontinued its phase III randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of... Read more
Singapore: Australia-based Alchemia has provided commercial update on four of its key projects, including its marketed drug fondaparinux;... Read more
Singapore: A new study by research and consulting firm GlobalData, highlighted that Japan's chronic myeloid leukemia (CML) market is going... Read more
Singapore: AstraZeneca is looking to move its research and global headquarters to Cambridge, UK, and has zeroed in on a site located at... Read more
Singapore: US-based Amgen is going to enter into a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma, in which Amgen will... Read more
Survey Box